Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Archives of Psychiatry and Clinical Neuroscience
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 4/2017

10.01.2017 | Letter to the Editor

A trans-diagnostic approach to psychosis, psychiatric medication nomenclature and stigma

verfasst von: Marina Economou, Helen Lazaratou

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Excerpt

Recent scientific advances stimulate thinking on the boundaries between normal and abnormal behaviour and the importance—both clinical and ethical—of the diagnoses we assign to people whose symptoms exceed a given threshold. In essence, psychosis is currently conceptualized as an (extended) continuous phenotype, which encompasses subclinical psychotic-like experiences in the general population [1]. Therefore a dimensional classification of mental disorders, in the context of a trans-diagnostic approach is substantiated. We cannot help but wonder how this new conceptualization may influence clinical practice, and especially with regard to the stigma attached to mental illness. …
Literatur
1.
van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population (2016). World Psychiatry 15:118–124.
2.
Schulze B, Angermeyer MC (2003) Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med 56:299–312CrossRefPubMed
3.
Corrigan P, Watson AC (2002) Understanding the impact of stigma on people with mental illness. World Psychiatry 1:16–20
4.
Lee S, Chin MY, Tsang A, Chui H, Kleinman A (2006) Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Honk Kong. Soc Sci Med 62:1685–1696CrossRefPubMed
5.
Hudson TJ, Thrush CR, Han X, Pyne JM, Thapa P, Sullivan G (2004) A pilot study of barriers to medication adherence in schizophrenia. J Clin Psychiatry 65:211–216CrossRefPubMed
6.
Sajatovic M, Jenkins JH (2007) Is antipsychotic medication stigmatizing for people with mental illness? Int Rev Psychiatry 19:107–112CrossRefPubMed
7.
Highet NJ, McNair BG, Thompson M, Davenport TA, Hickie IB (2004) Experience with treatment services for people with bipolar disorder. Med J Australia 181:S47–S51
8.
Sato M (2006) Renaming schizophrenia: a Japanese perspective. World Psychiatry 5:53–55
9.
10.
Fiorillo A, Luciano M, Del VEcchio V, Sampogna G, Obradors-Tarrago C, Maj M, ROMAER Consortium (2013) Priorities for mental health research in Europe: a survey among national stakeholders’ associations within the ROAMER project. World Psychiatry 12:165–170
11.
Thornicroft G (2006) Shunned: Discrimination against people with mental illness. Oxford University Press, Oxford
Metadaten
Titel
A trans-diagnostic approach to psychosis, psychiatric medication nomenclature and stigma
verfasst von
Marina Economou
Helen Lazaratou
Publikationsdatum
10.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 4/2017
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-016-0763-9

Weitere Artikel der Ausgabe 4/2017

European Archives of Psychiatry and Clinical Neuroscience 4/2017 Zur Ausgabe

Original Paper

The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis

Original Paper

Treatment recommendations for schizophrenia, major depression and alcohol dependence and stigmatizing attitudes of the public: results from a German population survey

Editorial

Gender does matter in clinical research

Original Paper

Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

Original Paper

Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies

Original Paper

Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns

Neu im Fachgebiet Psychiatrie

17.04.2024 | Delir nicht substanzbedingt | Nachrichten

Delir kann Demenz begünstigen

16.04.2024 | Störungen der Geschlechtsidentität | Nachrichten

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

12.04.2024 | Vitiligo | Nachrichten

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

09.04.2024 | Hyperhidrose | Nachrichten

Impostor-Syndrom häufig bei Hyperhidrose zu finden
weitere anzeigen

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen